Nan Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nan Lin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Dang Li
Fujian Key Laboratory of Vascular Aging, Department of Geriatrics, Fujian Institute of Geriatrics, Fujian Clinical Research Center for Senile Vascular Aging and Brain Aging, Fujian Medical University Union Hospital, Fuzhou, Fujian, People’s Republic of China
2 shared publications- En Huang
Key Laboratory of Brain Aging and Neurodegenerative Diseases of Fujian Province, Scientific Research Center, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian Province, China
2 shared publications Jianping Lu
2 shared publications- Jianping Lu
Department of Neurology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian 350001, China; Institute of Clinical Neurology, Fujian Medical University, 88 Jiaotong Road, Fuzhou, Fujian Province 350001, China
2 shared publications - Qinyong Ye
Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China
2 shared publications Si Lin
2 shared publications
Latest Publications
- 25 May 2026
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 137, 106832
Platelet factor 4 prevents neuroinflammation and neurodegeneration in Parkinson’s disease model via regulating protocadherin gamma/Pyk2 pathway
- 25 May 2026
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 137, 106832
Platelet factor 4 prevents neuroinflammation and neurodegeneration in Parkinson’s disease model via regulating protocadherin gamma/Pyk2 pathway
- Open Access
- 14 February 2026
- Published by Elsevier in International Emergency Nursing
- Vol. 85, 101765
Interactive effects of cardiac arrest duration and lactate levels on six-month mortality in patients surviving cardiac arrest and cardiopulmonary resuscitation
- 14 February 2026
- Published by Elsevier in International Emergency Nursing
- Vol. 85, 101765
Open AccessInteractive effects of cardiac arrest duration and lactate levels on six-month mortality in patients surviving cardiac arrest and cardiopulmonary resuscitation
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Genomics
- Vol. 2026 (1) , 2340381
The Relationship of Peripheral Glycoprotein Nonmetastatic Melanoma Protein B and Parkinson′s Disease: Insights From a Mendelian Randomization Study
Background: Genome‐wide association studies (GWASs) have revealed that glycoprotein nonmetastatic melanoma Protein B (GPNMB) was associated with Parkinson′s disease (PD). GPNMB has been found in plasma and cerebrospinal fluid, and its levels and the variation of single nucleotide polymorphisms (SNPs) have been linked to disease severity in PD patients. However, whether the altered expression of GPNMB is the cause or the result cannot be identified in the patient samples. Methods: This study applied a Mendelian randomization analysis to explore the causal relationship between GPNMB and PD. The blood GPNMB mRNA level from the expression quantitative trait loci (eQTL) dataset and the plasma GPNMB protein level from the protein quantitative trait loci (pQTL) acted as the exposure. PD′s GWAS dataset from the International Parkinson′s Disease Genomics Consortium including 33674 PD cases and 449056 normal controls was applied as the outcome. Results: MR analysis with the inverse‐variant weighted method (IVW, OR = 1.416, p = 1.39 e − 06) and the weighted median methods (WM, OR = 1.430, p = 4.47 e − 07) showed that the plasma GPNMB protein expression was linked to a higher risk of PD. We also discovered a significant association between the blood mRNA level of GPNMB and PD risk. The IVW (OR = 1.243, p = 3.64 e − 09) and WM (OR = 1.237, p = 5.11 e − 08) methods share similar results. Secondary MR analysis further reveals causality between GPNMB pQTL/eQTL and brain volume traits. Conclusions: The study demonstrated a significant association between plasma GPNMB protein (pQTL) and mRNA level (eQTL) with PD. Further secondary MR analysis revealed causality between GPNMB pQTL/eQTL and brain volume traits.
- 1 January 2026
- Published by Wiley in International Journal of Genomics
- Vol. 2026 (1) , 2340381
Open AccessThe Relationship of Peripheral Glycoprotein Nonmetastatic Melanoma Protein B and Parkinson′s Disease: Insights From a Mendelian Randomization Study
Background: Genome‐wide association studies (GWASs) have revealed that glycoprotein nonmetastatic melanoma Protein B (GPNMB) was associated with Parkinson′s disease (PD). GPNMB has been found in plasma and cerebrospinal fluid, and its levels and the variation of single nucleotide polymorphisms (SNPs) have been linked to disease severity in PD patients. However, whether the altered expression of GPNMB is the cause or the result cannot be identified in the patient samples. Methods: This study applied a Mendelian randomization analysis to explore the causal relationship between GPNMB and PD. The blood GPNMB mRNA level from the expression quantitative trait loci (eQTL) dataset and the plasma GPNMB protein level from the protein quantitative trait loci (pQTL) acted as the exposure. PD′s GWAS dataset from the International Parkinson′s Disease Genomics Consortium including 33674 PD cases and 449056 normal controls was applied as the outcome. Results: MR analysis with the inverse‐variant weighted method (IVW, OR = 1.416, p = 1.39 e − 06) and the weighted median methods (WM, OR = 1.430, p = 4.47 e − 07) showed that the plasma GPNMB protein expression was linked to a higher risk of PD. We also discovered a significant association between the blood mRNA level of GPNMB and PD risk. The IVW (OR = 1.243, p = 3.64 e − 09) and WM (OR = 1.237, p = 5.11 e − 08) methods share similar results. Secondary MR analysis further reveals causality between GPNMB pQTL/eQTL and brain volume traits. Conclusions: The study demonstrated a significant association between plasma GPNMB protein (pQTL) and mRNA level (eQTL) with PD. Further secondary MR analysis revealed causality between GPNMB pQTL/eQTL and brain volume traits.
- Open Access
- 1 July 2025
- Published by KEAI Publishing in Brain Hemorrhages
Grading of acute spontaneous cerebral hemorrhage combined with gut dysfunction assessment as a novel and improved prognostic score
- 1 July 2025
- Published by KEAI Publishing in Brain Hemorrhages
Open AccessGrading of acute spontaneous cerebral hemorrhage combined with gut dysfunction assessment as a novel and improved prognostic score
- Open Access
- 1 December 2024
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 19, 2165-2166
Enhancing the Predictive Utility of MHR for Senile Osteoporosis: Unaddressed Considerations and Future Directions [Response to Letter]
Response to Letter in regards to Enhancing the Predictive Utility of MHR for Senile Osteoporosis: Unaddressed Considerations and Future Directions [Letter]
- 1 December 2024
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 19, 2165-2166
Open AccessEnhancing the Predictive Utility of MHR for Senile Osteoporosis: Unaddressed Considerations and Future Directions [Response to Letter]
Response to Letter in regards to Enhancing the Predictive Utility of MHR for Senile Osteoporosis: Unaddressed Considerations and Future Directions [Letter]
- Open Access
- 1 November 2024
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 19, 1773-1788
The Monocyte-to-High-Density Lipoprotein Cholesterol Ratio as a Novel Predictor of the Prevalence of Senile Osteoporosis
Purpose: The prevalence of osteoporosis in elderly individuals is high, and osteoporosis is strongly associated with chronic inflammation. The monocyte-to-high-density lipoprotein ratio (MHR) is acknowledged as a marker for assessing systemic inflammation and oxidative stress, and changes in the MHR are associated with many chronic disease prevalent among the elderly population. This study investigated the relationships between the MHR and the incidence of osteoporosis in older adults, along with its predictive value. Patients and Methods: Data from 563 participants aged ≥ 70 years were retrospectively analysed. The haematological parameters were evaluated via established methodologies, utilizing fasting blood samples collected from the participants. The absolute monocyte count was used to calculate the MHR (MHR=monocyte/HDL-C). BMD was measured by dual-energy X-ray absorptiometry. The results were evaluated via comparative statistical analyses, Spearman correlation, logistic regression analyses, and receiver operating characteristic (ROC) curve analysis. Results: The differences in the MHR were statistically significant among the osteoporosis groups (p < 0.001). Spearman correlation analysis revealed a positive correlation between the MHR and BMD. Furthermore, stratifying the sample into four groups on the basis of quartiles of MHR (M1, M2, M3, and M4) revealed a decreased risk of osteoporosis in the highest quartile compared with the lowest quartile (p < 0.001). Multiple logistic regression analysis revealed that BMI and the MHR were independent risk factors for osteoporosis. The area under the ROC curve and the cut-off value of the MHR were 0.710 and 0.308(109/mmol), with specificity and sensitivity of 0.599 and 0.735, respectively (95% CI: 0.668~0.752, p < 0.0001). Conclusion: A low MHR was associated with a greater risk of senile osteoporosis. In clinical practice, the MHR has shown predictive value for senile osteoporosis, contributing to early intervention and treatment of this disease.
- 1 November 2024
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 19, 1773-1788
Open AccessThe Monocyte-to-High-Density Lipoprotein Cholesterol Ratio as a Novel Predictor of the Prevalence of Senile Osteoporosis
Purpose: The prevalence of osteoporosis in elderly individuals is high, and osteoporosis is strongly associated with chronic inflammation. The monocyte-to-high-density lipoprotein ratio (MHR) is acknowledged as a marker for assessing systemic inflammation and oxidative stress, and changes in the MHR are associated with many chronic disease prevalent among the elderly population. This study investigated the relationships between the MHR and the incidence of osteoporosis in older adults, along with its predictive value. Patients and Methods: Data from 563 participants aged ≥ 70 years were retrospectively analysed. The haematological parameters were evaluated via established methodologies, utilizing fasting blood samples collected from the participants. The absolute monocyte count was used to calculate the MHR (MHR=monocyte/HDL-C). BMD was measured by dual-energy X-ray absorptiometry. The results were evaluated via comparative statistical analyses, Spearman correlation, logistic regression analyses, and receiver operating characteristic (ROC) curve analysis. Results: The differences in the MHR were statistically significant among the osteoporosis groups (p < 0.001). Spearman correlation analysis revealed a positive correlation between the MHR and BMD. Furthermore, stratifying the sample into four groups on the basis of quartiles of MHR (M1, M2, M3, and M4) revealed a decreased risk of osteoporosis in the highest quartile compared with the lowest quartile (p < 0.001). Multiple logistic regression analysis revealed that BMI and the MHR were independent risk factors for osteoporosis. The area under the ROC curve and the cut-off value of the MHR were 0.710 and 0.308(109/mmol), with specificity and sensitivity of 0.599 and 0.735, respectively (95% CI: 0.668~0.752, p < 0.0001). Conclusion: A low MHR was associated with a greater risk of senile osteoporosis. In clinical practice, the MHR has shown predictive value for senile osteoporosis, contributing to early intervention and treatment of this disease.
- Open Access
- 1 January 2021
- Published by Walter de Gruyter GmbH in Translational Neuroscience
- Vol. 12 (1) , 301-308
Tripchlorolide attenuates β-amyloid generation by inducing NEP activity in N2a/APP695 cells
Background and purpose: Alzheimer’s disease (AD) is a neurodegeneration disease. The previous work from our research group demonstrated the neuroprotective effects of tripchlorolide (T4) in AD animal models. Materials and methods: Neprilysin (NEP) is known as an important physiological amyloid-β protein (Aβ) peptide-degrading enzyme in the brain due to its apparent rate-limiting function. In this study, we explored the effect of NEP on AD model N2a/APP695 cells. Western blots and enzyme-linked immunosorbent assays were performed to assess the expression of proteins, while quantitative real-time polymerase chain reaction assays were used to evaluate RNA levels. Cell vitality was detected by the MTT assay, and reactive oxygen species (ROS) levels were assessed using a ROS activity assay kit. Results: We discovered that T4 was able to enhance the enzyme activity of NEP. T4 administration decreased the protein levels of the soluble amyloid precursor protein. In further experiments, we found that by using thiorphan the secretion of Aβ, oxidative stress, nitrosative stress, and inflammatory factors, which were suppressed by T4, were reversed. Due to its ability to attenuate Aβ generation and to protect neurons against the neurotoxicity of Aβ, T4 may be a potential therapy in the regulation of Aβ-related pathology in AD by affecting NEP activity. Conclusion: Tripchlorolide attenuates Aβ generation by inducing NEP activity in N2a/APP695 cells.
- 1 January 2021
- Published by Walter de Gruyter GmbH in Translational Neuroscience
- Vol. 12 (1) , 301-308
Open AccessTripchlorolide attenuates β-amyloid generation by inducing NEP activity in N2a/APP695 cells
Background and purpose: Alzheimer’s disease (AD) is a neurodegeneration disease. The previous work from our research group demonstrated the neuroprotective effects of tripchlorolide (T4) in AD animal models. Materials and methods: Neprilysin (NEP) is known as an important physiological amyloid-β protein (Aβ) peptide-degrading enzyme in the brain due to its apparent rate-limiting function. In this study, we explored the effect of NEP on AD model N2a/APP695 cells. Western blots and enzyme-linked immunosorbent assays were performed to assess the expression of proteins, while quantitative real-time polymerase chain reaction assays were used to evaluate RNA levels. Cell vitality was detected by the MTT assay, and reactive oxygen species (ROS) levels were assessed using a ROS activity assay kit. Results: We discovered that T4 was able to enhance the enzyme activity of NEP. T4 administration decreased the protein levels of the soluble amyloid precursor protein. In further experiments, we found that by using thiorphan the secretion of Aβ, oxidative stress, nitrosative stress, and inflammatory factors, which were suppressed by T4, were reversed. Due to its ability to attenuate Aβ generation and to protect neurons against the neurotoxicity of Aβ, T4 may be a potential therapy in the regulation of Aβ-related pathology in AD by affecting NEP activity. Conclusion: Tripchlorolide attenuates Aβ generation by inducing NEP activity in N2a/APP695 cells.